Nesfatin-1: A Novel Diagnostic and Prognostic Biomarker in Digestive Diseases

Adriana-Cezara Damian-Buda,Daniela Maria Matei,Lidia Ciobanu,Dana-Zamfira Damian-Buda,Raluca Maria Pop,Anca Dana Buzoianu,Ioana Corina Bocsan
DOI: https://doi.org/10.3390/biomedicines12081913
IF: 4.757
2024-08-21
Biomedicines
Abstract:Nesfatin-1, deriving from a precursor protein, NUCB2, is a newly discovered molecule with anti-apoptotic, anti-inflammatory, antioxidant, and anorexigenic effects. It was initially identified in the central nervous system (CNS) and received increasing interest due to its energy-regulating properties. However, research showed that nesfatin-1 is also expressed in peripheral tissues, including the digestive system. The aim of this review is to give a résumé of the present state of knowledge regarding its structure, immunolocalization, and potential implications in diseases with inflammatory components. The main objective was to focus on its clinical importance as a diagnostic biomarker and potential therapeutic molecule in a variety of disorders, among which digestive disorders were of particular interest. Previous studies have shown that nesfatin-1 regulates the balance between pro- and antioxidant agents, which makes nesfatin-1 a promising therapeutic agent. Further in-depth research regarding the underlying mechanisms of action is needed for a better understanding of its effects.
biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
What problem does this paper attempt to address?